周四， STAAR Surgical Company 盘中拉升，暴涨超25%。公司公布的第一财季初步净销售额超过9000万美元，大幅高于去年同期的4260万美元。FactSet调查的分析师此前预计净销售额为6760万美元。
此外，Canaccord Genuity将STAAR Surgical的股票评级从“持有”上调至“买入”，同时将其目标价从22美元上调至27美元。
周四， STAAR Surgical Company 盘中拉升，暴涨超25%。公司公布的第一财季初步净销售额超过9000万美元，大幅高于去年同期的4260万美元。FactSet调查的分析师此前预计净销售额为6760万美元。
此外，Canaccord Genuity将STAAR Surgical的股票评级从“持有”上调至“买入”，同时将其目标价从22美元上调至27美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
